bluebird bio (NASDAQ:BLUE) reported first-quarter earnings last week, but like the biotech typically does, management didn't hold a conference call, which makes the earnings release more of a rehash of the quarter than an actual update.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,